Gene · 7272
Papers3,094
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,094
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune-related biomarkers predict the prognosis and immune response of breast cancer based on bioinformatic analysis and machine learning. | Funct Integr Genomics | 2023 | 37291471 | PubTator, text mining | PubMed |
| Identification of evolutionary mechanisms of myelomatous effusion by single-cell RNA sequencing. | Blood Adv | 2023 | 37276129 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis uncovers intratumoral heterogeneity and drug-tolerant persister in ALK-rearranged lung adenocarcinoma. | Cancer Commun (Lond) | 2023 | 37272226 | PubTator, text mining | PubMed |
| FOXM1 Contributes to Chemotherapy Sensitivity in Cervical Cancer by Regulating TTK. | Discov Med | 2023 | 37272088 | PubTator, text mining | PubMed |
| What spelling errors can tell us about the development of processes involved in children's spelling. | Front Psychol | 2023 | 37251015 | PubTator, text mining | PubMed |
| HMGA1 and FOXM1 Cooperate to Promote G2/M Cell Cycle Progression in Cancer Cells. | Life (Basel) | 2023 | 37240870 | PubTator, text mining | PubMed |
| The Inability to Disassemble Rad51 Nucleoprotein Filaments Leads to Aberrant Mitosis and Cell Death. | Biomedicines | 2023 | 37239121 | PubTator, text mining | PubMed |
| Identification, characterization, and prognosis investigation of pivotal genes shared in different stages of breast cancer. | Sci Rep | 2023 | 37231064 | PubTator, text mining | PubMed |
| Augmenting bioactivity by docking-generated multiple ligand poses to enhance machine learning and pharmacophore modelling: discovery of new TTK inhibitors as case study. | Mol Inform | 2023 | 37222400 | PubTator, text mining | PubMed |
| Stable kinetochore-microtubule attachment requires loop-dependent Ndc80-Ndc80 binding. | EMBO J | 2023 | 37203876 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma. | J Thorac Dis | 2023 | 37197486 | PubTator, text mining | PubMed |
| The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response. | Front Oncol | 2023 | 37197417 | PubTator, text mining | PubMed |
| KIF4A Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Proliferation in vitro and in vivo [Retraction]. | Onco Targets Ther | 2023 | 37192931 | PubTator, text mining | PubMed |
| Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003. | Front Pharmacol | 2023 | 37188272 | PubTator, text mining | PubMed |
| Bioinformatics Approach to Identify the Influences of COVID-19 on Ischemic Stroke. | Biochem Genet | 2023 | 37184686 | PubTator, text mining | PubMed |
| [Progress in the Study of Spindle Assembly Checkpoint in Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2023 | 37183646 | PubTator, text mining | PubMed |
| The Potential of Cylindromatosis (CYLD) as a Therapeutic Target in Oxidative Stress-Associated Pathologies: A Comprehensive Evaluation. | Int J Mol Sci | 2023 | 37176077 | PubTator, text mining | PubMed |
| Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma. | Discov Oncol | 2023 | 37160815 | PubTator, text mining | PubMed |
| Comprehensive analyses reveal the prognosis and biological function roles of chromatin regulators in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37155150 | PubTator, text mining | PubMed |
| AURKA, TOP2A and MELK are the key genes identified by WGCNA for the pathogenesis of lung adenocarcinoma. | Oncol Lett | 2023 | 37153047 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7272/papers?page=20